nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2017, 09, v.19;No.161 161-163
清热益气法联合西药治疗冠心病心绞痛疗效及不良事件预防效果研究
基金项目(Foundation): 河北省中医药管理局科研计划项目(2014252)
邮箱(Email):
DOI: 10.13194/j.issn.1673-842x.2017.09.045
摘要:

目的:探讨清热益气法联合西药治疗冠心病心绞痛患者的疗效以及对不良事件的预防效果。方法:选取2015年2月—2016年3月在我院接受治疗的冠心病心绞痛患者100例,采用随机数表法将所有的入选患者分为观察组和对照组两组,每组各50例,对照组患者给予西药治疗,观察组患者给予清热益气法联合西药治疗,比较两组患者治疗后血液流变学变化、血脂变化、临床疗效以及不良反应发生率情况。结果:治疗后,两组患者的血浆黏度、全血黏度以及纤维蛋白都有所下降,观察组(1.02±0.12)mpa·s、(2.13±0.56)mpa·s、(2.12±0.56)g/L低于对照组(2.12±0.30)mpa·s、(3.78±0.19)mpa·s、(3.02±0.26)g/L,两组比较差异显著(P<0.05);治疗后,两组患者的TG以及TC都有所下降,观察组(0.98±0.12)、(3.12±0.78)mmol/L低于对照组(1.56±0.13)、(4.98±0.99)mmol/L,两组比较差异显著(P<0.05);两组患者的HDL-C都有所升高,观察组(1.98±0.20)mmol/L高于对照组(1.10±0.09)mmol/L,两组比较差异显著(P<0.05);观察组患者治疗后的总有效率为96.00%高于对照组78.00%,两组比较差异显著(P<0.05)。两组患者治疗后不良反应发生率比较无统计学意义(P>0.05)。结论:清热益气法联合西药治疗冠心病心绞痛患者,可有效提高临床治疗效果且不良反应发生率低。

Abstract:

Objective:To investigate the efficacy of Qingre Yiqi method combined with Western medicine in the treatment of angina pectoris of coronary heart disease and the preventive effect of adverse events. Methods:100 patients with angina pectoris of coronary heart disease treated in our hospital from February,2015 to March,2016 were randomly divided into two groups:observation group and control group,50 cases in each group,The patients in the control group were treated with Western medicine. The patients in the observation group were treated with Qingre Yiqi method combined with Western medicine. The changes of hemorheology,blood lipid,clinical efficacy and the incidence of adverse reactions were compared between the two groups. Results:After treatment,the plasma viscosity,whole blood viscosity and fibrin of the two groups decreased(1.02±0.12)mpa·s,(2.13±0.56)mpa·s,(2.12±0.56)g/L in the observation group(2.12±0.30)mpa·s,(3.78±0.19)mpa·s,(3.02±0.26)g/L. There was significant difference between the two groups(P<0.05). After treatment,both TG and TC in the observation group(0.98±0.12),(3.12±0.78)mmol/L was significantly lower than that in the control group(1.56±0.13),(4.98±0.99)mmol/L. There was significant difference between the two groups(P<0.05). HDL-C in the observation group(1.98±0.20)mmol/L was significantly higher than that in the control group(1.10±0.09)mmol/L,the difference between the two groups was significant(P<0.05);the total effective rate in the observation group 96.00% higher than the control group 78.00%,the difference between the two groups was significant(P<0.05). There was no significant difference between the two groups in the incidence of adverse reactions after treatment(P>0.05). Conclusion:Qingre Yiqi method combined with western medicine treatment of angina pectoris in patients with coronary heart disease can effectively improve the clinical efficacy and adverse reaction rate is low.

参考文献

[1]樊蓉,任天舒,赵庆春,等.西药常规治疗联用通心络胶囊治疗冠心病心绞痛疗效的荟萃分析[J].药学实践杂志,2015,12(1):83-87.

[2]王艳霞.丹七软胶囊结合西药治疗老年冠心病心绞痛疗效观察[J].湖北中医药大学学报,2016,18(2):66-69.

[3]蔡兴芬,陈龙胜,吴春美,等.血府逐瘀汤联合西药治疗冠心病心绞痛的疗效观察及其对血液流变学影响[J].中国中医药科技,2015,22(3):317-318.

[4]赵振霞,贾奎,王进,等.冠心通脉胶囊联合西药治疗心肾阳虚型冠心病心绞痛的研究[J].现代中西医结合杂志,2015,23(11):1144-1146,1176.

[5]占甘伟,汪宏良,李艳,等.益气养阴活血汤联合西药对冠心病心绞痛血清C反应蛋白、肿瘤坏死因子-α、血脂水平、血液流变学水平的影响[J].国际检验医学杂志,2016,37(7):935-937.

[6]Werdan K,Ebelt H,Nuding S,et al.Vabradine in combination with metoprolol improves symptoms and quality of life in patients with stable angina pectoris:A post hoc analysis from the ADDITIONS trial[J].Cardiology,2016,133(2):83-90.

[7]邓椿桥,邓永文.活血定痛汤联合单硝酸异山梨酯等西药治疗心脉瘀阻型冠心病心绞痛70例疗效观察[J].中国医药指南,2013,25(34):216-217.

[8]程国斌.用活血定痛汤联合西药治疗心脉瘀阻型冠心病心绞痛的效果观察[J].当代医药论丛,2014,18(15):181-181.

[9]刘继强.益气活血通络法联合西药治疗冠心病心绞痛患者45例临床观察[J].中国中医药科技,2016,23(3):340-342.

[10]丁桂敏.用丹参川芎嗪注射液联合西药治疗冠心病心绞痛的临床疗效观察[J].当代医药论丛,2014,26(2):54-54.

[11]吴阳胜.芪参益气滴丸联合西药治疗冠心病心绞痛气虚血瘀证的疗效及对心功能和内皮功能的影响[J].黑龙江医药,2016,29(1):89-90.

[12]LI Z,LIU X,WANG J,et al.Analysis of urinary metabolomic profiling for unstable angina pectoris disease based on nuclear magnetic resonance spectroscopy[J].Molecular bio Systems,2015,11(12):3387-3396.

[13]谢玉霞,晋卫军,程璐,等.瓜蒌皮注射液联合西药治疗冠心病心绞痛(痰瘀互阻证)合并心衰患者的临床研究[J].实用中西医结合临床,2014,14(7):16-17,20.

[14]Soran O.Alternative therapy for medically refractory angina:enhanced external counterpulsation and transmyocardial laser revascularization[J].Heart failure clinics,2016,12(1):107-116.

[15]付华宾,彭志群,胡孟泉,等.参芎葡萄糖注射液联合西药治疗冠心病心绞痛的临床效果观察[J].中国当代医药,2013,20(34):103-104,106.

[16]陈慧敏,许逸飞.曲美他嗪联合阿托伐他汀钙治疗冠心病心绞痛伴血脂异常的临床研究[J].中国临床药理学杂志,2016,32(11):966-968.

[17]刘虹宏,刘兆川,刘红涛,等.2型糖尿病伴冠心病心绞痛患者血栓弹力图分析及其与病情严重程度的相关性分析[J].海南医学院学报,2016,22(1):30-32,36.

[18]倪林,夏向阳,韩卡,等.合并焦虑和抑郁情绪对冠心病心绞痛患者内皮功能及炎症反应的影响[J].海南医学院学报,2016,22(1):33-36.

[19]占甘伟,汪宏良,李艳,等.益气养阴活血汤联合西药对冠心病心绞痛血清C反应蛋白、肿瘤坏死因子-α、血脂水平、血液流变学水平的影响[J].国际检验医学杂志,2016,37(7):935-937.

[20]钟耀棠,李诗成,杜英,等.银杏达莫注射液对冠心病心绞痛患者血液流变学指标及血清肿瘤坏死因子α、细胞间黏附分子1、C反应蛋白水平的影响研究[J].实用心脑肺血管病杂志,2016,24(8):89-91,92.

基本信息:

DOI:10.13194/j.issn.1673-842x.2017.09.045

中图分类号:R541.4

引用信息:

[1]杜鸿瑶,宋郁珍.清热益气法联合西药治疗冠心病心绞痛疗效及不良事件预防效果研究[J].辽宁中医药大学学报,2017,19(09):161-163.DOI:10.13194/j.issn.1673-842x.2017.09.045.

基金信息:

河北省中医药管理局科研计划项目(2014252)

发布时间:

2017-08-04

出版时间:

2017-08-04

网络发布时间:

2017-08-04

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文